305 related articles for article (PubMed ID: 31982510)
21. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
22. DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network.
Wu J; Li X; Wang Q; Han J
Bioinformatics; 2022 Oct; 38(21):4975-4977. PubMed ID: 36066432
[TBL] [Abstract][Full Text] [Related]
23. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
24. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
[TBL] [Abstract][Full Text] [Related]
25. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
26. Drug Repurposing in Anticancer Reagent Development.
Chen PC; Liu X; Lin Y
Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
[TBL] [Abstract][Full Text] [Related]
27. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
28. Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
Jung JH; Hwang J; Kim JH; Sim DY; Im E; Park JE; Park WY; Shim BS; Kim B; Kim SH
Semin Cancer Biol; 2021 Jan; 68():164-174. PubMed ID: 31883914
[TBL] [Abstract][Full Text] [Related]
29. Drug repurposing-an emerging strategy in cancer therapeutics.
Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
[TBL] [Abstract][Full Text] [Related]
30. Current state and future perspective of drug repurposing in malignant glioma.
Siegelin MD; Schneider E; Westhoff MA; Wirtz CR; Karpel-Massler G
Semin Cancer Biol; 2021 Jan; 68():92-104. PubMed ID: 31734137
[TBL] [Abstract][Full Text] [Related]
31. Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy.
Gustafson DL; Fowles JS; Brown KC; Theodorescu D
Assay Drug Dev Technol; 2015 Dec; 13(10):623-7. PubMed ID: 26690765
[TBL] [Abstract][Full Text] [Related]
32. In Silico Oncology Drug Repositioning and Polypharmacology.
Cheng F
Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
[TBL] [Abstract][Full Text] [Related]
33. Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.
Weth FR; Hoggarth GB; Weth AF; Paterson E; White MPJ; Tan ST; Peng L; Gray C
Br J Cancer; 2024 Mar; 130(5):703-715. PubMed ID: 38012383
[TBL] [Abstract][Full Text] [Related]
34. Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review.
Selvaraj J; Prabha T; Yadav N
Curr Drug Res Rev; 2021; 13(1):3-15. PubMed ID: 32838729
[TBL] [Abstract][Full Text] [Related]
35. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
Chen H; Wu J; Gao Y; Chen H; Zhou J
Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
[TBL] [Abstract][Full Text] [Related]
36. Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.
Yang H; Chen X; Li K; Cheaito H; Yang Q; Wu G; Liu J; Dou QP
Semin Cancer Biol; 2021 Jan; 68():105-122. PubMed ID: 31883910
[TBL] [Abstract][Full Text] [Related]
37. Small-molecule drug repurposing to target DNA damage repair and response pathways.
Brinkman JA; Liu Y; Kron SJ
Semin Cancer Biol; 2021 Jan; 68():230-241. PubMed ID: 32113999
[TBL] [Abstract][Full Text] [Related]
38. New drugs are not enough‑drug repositioning in oncology: An update.
Armando RG; Mengual Gómez DL; Gomez DE
Int J Oncol; 2020 Mar; 56(3):651-684. PubMed ID: 32124955
[TBL] [Abstract][Full Text] [Related]
39. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.
Sohraby F; Aryapour H
Semin Cancer Biol; 2021 Jan; 68():249-257. PubMed ID: 32360530
[TBL] [Abstract][Full Text] [Related]
40. Structure-based drug repositioning: Potential and limits.
Adasme MF; Parisi D; Sveshnikova A; Schroeder M
Semin Cancer Biol; 2021 Jan; 68():192-198. PubMed ID: 32032699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
